Prion disease: Possible implications for oral health care

Journal of the American Dental Association

Volumn 134, Issue 11, 2003, Pages 1486-1491

  Porter, Stephen R ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIDINE DERIVATIVE; AMYLOID; CHLORPROMAZINE; PHENOTHIAZINE DERIVATIVE; POLYAMINE; QUINICRINE; UNCLASSIFIED DRUG;

CLINICAL FEATURE; CREUTZFELDT JAKOB DISEASE; DEATH; DENTAL CARE; DENTAL HEALTH; DISEASE COURSE; EUROPE; EXPERIMENT; GINGIVA DISEASE; HEALTH CARE; HOSPITAL INFECTION; HUMAN; IATROGENIC DISEASE; INFECTION CONTROL; INFECTION RISK; INHERITANCE; KURU; MENTAL DISEASE; MOUTH; MOUTH INFECTION; MOUTH MUCOSA; NEUROLOGIC DISEASE; NONHUMAN; PATHOGENESIS; PRION; PRION DISEASE; REVIEW; RISK ASSESSMENT; SENESCENCE; TOOTH PULP; VIRUS DETECTION; VIRUS TRANSMISSION;

EID: 0346789031     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2003.0079     Document Type: Article

References (52)

1. Collinge J. Prion diseases of humans and animals: their causes and molecular basis. Annu Rev Neurosci 2002;24:519-50.
2. Prusiner SB, Hadlow WJ, Eklund CM, Race RE. Sedimentation properties of the scrapie agent. Proc Natl Acad Sci USA 1997;74:4656-60.
3. Mitka M. FDA wants more restrictions on donated blood. JAMA 2001;286:408.
4. Hsiao KK, Cass C, Schellenberg GD, et al. A prion protein variant in a family with the telencephalic form of Gerstmann-Straussler-Scheinker syndrome. Neurology 1991;41:681-4.
5. Giaccone G, Verga L, Bugiani O, et al. Prion protein preamyloid and amyloid deposits in Gerstmann-Straussler-Scheinker disease, Indiana kindred. Proc Natl Acad Sci U S A 1992;89:9349-53.
6. Belay ED, Gambetti P, Schonberger LB, et al. Creutzfeldt-Jakob disease in unusually young patients who consumed venison. Arch Neurol 2001;58:1673-8.
7. Marsh RF, Bessen RA, Lehmann S, Hartsough GR. Epidemological and experimental studies on a new incident of transmissible mink encephalopathy. J Gen Virol 1991;72:589-94.
8. Westaway D, Zuliani V, Cooper CM, et al. Homozygosity for prion protein alleles encoding glutamine-171 renders sheep susceptible to natural scrapie. Genes Dev 1994;8:959-69.
9. Spraker TR, Miller MW, Williams ES, et al. Spongiform encephalopathy in free-ranging mule deer (Odoncoileus hemionus), white-tailed deer (Odocoileus virginianus) and Rocky Mountain elk (Cervus elphus nelsoni) in northcentral Colorado. J Wildl Dis 1997;33:1-6.
10. Peters J, Miller JM, Jenny AL, Peterson TL, Carmichael KP. Immunohistochemical diagnosis of chronic wasting disease in preclinically affected elk from a captive herd. J Vet Diagn Invest 2000;12: 579-82.
11. Wells GA, Scott AC, Johnson CT, et al. A novel progressive spongiform encephalopathy in cattle. Vet Rec 1987;121:419-20.
12. Prusiner SB. The prion diseases. Brain Pathol 1998;8:499-513.
13. Weber T, Aguzzi A. The spectrum of transmissible spongiform encephalopathies. Intervirology 1997;40:198-212.
14. Ironside JW. Human prion diseases. J Neural Transm Suppl 1996;47:231-46.
15. Prusiner SB. Molecular biology and pathogenesis of prion diseases. Trends Biochem Sci 1996;21:482-7.
16. Jackson GS, Collinge J. The molecular pathology of CJD: old and new variants. J Clin Pathol 2001;54:393-9.
17. Zigas V. Kuru: a critical review. Med J Aust 1975;2:483-6.
18. Collinge J, Palmer MS. Prion diseases. Oxford, England: Oxford University Press; 1997:30-2.
19. Cousens SN, Zeidler M, Esmonde TF, et al. Sporadic Creutzfeldt-Jakob disease in the United Kingdom: analysis of epidemiological surveillance data for 1970-96. BMJ 1997;315:389-96.
20. Lantos PL. From slow virus to prion protein: a review of transmissible spongiform encephalopathies. Histopathology 1992;20:1-11.
21. Hill AF, Butterworth RJ, Joiner S, et al. Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsillar biopsy samples. Lancet 1999;353:189-93.
22. Brown P, Preece M, Brandel J-P, et al. Latrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 2000;55:1075-81.
23. Frosh A, Joyce R, Johnson A. Iatrogenic vCJD from surgical instruments. Br Med J 2001;322:1558-9.
24. Will RG, Ironside JW, Zeidler M, et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 1996;347:921-5.
25. Will RG, Zeidler M, Stewart GE, et al. Diagnosis of new variant Creutzfeldt-Jakob disease. Ann Neurol 2000;47:575-82.
26. Department of Health. Creutzfeldt-Jakob disease (CJD) & bovine spongiform encephalopathy (BSE). Available at: "www.doh.gov.uk/cjd/". Accessed Sept. 16, 2003.
27. Ironside JW, Hilton DA, Ghani A, et al. Retrospective study of prion protein accumulation in tonsil and appendix tissues. Lancet 2000;355:1693-4.
28. Brown P. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Br Med J 2001;322:841-4.
29. Brown P, Will RG, Bradley R, Asher DM, Detwiler L. Bovine spongiform encephalopathy and variant Creutzfeldt-Jakob disease. Emerg Infect Dis 2001;7:1-13.
30. Korth C, May BCH, Cohen FE, Prusiner SB. Acridine and phenothiazine derivatives as pharmacotherapeutics for prion disease. Proc Natl Acad Sci USA 2001;98:9836-41.
31. Mallucci GR, Ratte S, Asante EA, et al. Post-natal knockout of prion protein alters hippocampal CA1 properties, but does not result in neurodegeneration. EMBO J 2002;3:202-10.
32. Zeidler M, Johnstone EC, Bamber RW, et al. New variant Creutzfeldt-Jakob disease: psychiatric features. Lancet 1997;350: 908-10.
33. Reuber M, Al-Din AS, Barborie A, Chakrabarty A. New variant Creutzfeldt-Jakob disease presenting with loss of taste and smell. J Neurol Neurosurg Psychiatry 2001;71:412-3.
34. Will RG, Matthews WB. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 1982;45: 235-8.
35. Arakawa K, Nagara H, Itoyama Y, et al. Clustering of three cases of Creutzfeldt-Jakob disease near Fukuoka City, Japan. Acta Neurol Scand 1991;84:445-7.
36. Zerr I, Brandel J-P, Masullo C, et al. European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol 2000;53:747-54.
37. Guiroy DC, Shankar SK, Gibbs J, Messenheimer JA, Das S, Gajdusek DC. Neuronal degeneration and neurofilament accumulation in the trigeminal ganglia in Creutzfedt-Jakob disease. Ann Neurol 1989;25:102-6.
38. Wells GA, Hawkins SA, Green RB, et al. Preliminary observations on the pathogenesis of experimental bovine spongiform encephalopathy (BSE): an update. Vet Rec 1998;142:103-6.
39. Ingrosso L, Pisani F, Pocchoria M. Transmission of the 263 scrapie strain by the dental route. J Gen Virol 1999;80:3043-7.
40. Blanquet-Grossard F, Sazdovich V, Jean A, et al. Prion protein is not detectable in dental pulp from patients with Creutzfeldt-Jakob disease. J Dent Res 2000;79:700.
41. Pattison IH, Jones KM, Jebbett JN. Detection of the scrapie agent in tissues of normal mice with special reference to the possibility of accidental laboratory contamination. Res Vet Sci 1971;12:30-9.
42. Adams DH, Edgar WM. Transmission of agent of Creutzfeldt-Jakob disease. Br Med J 1978;1:987.
43. Carp RI. Transmission of scrapie by oral route: effect of gingival scarification. Lancet 1982;1:170-1.
44. Lodi G, Porter SR, Scully C. Hepatitis C virus infection: review and implications for the dentist. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:8-22.
45. Public Health Laboratory Service. Occupational transmission of HIV; summary of published reports. Available at: "www.hpa. org.uk/infections/ topics_az/hiv_and_sti/publications/hiv_octr_1999.pdf". Accessed Sept. 29, 2003.
46. Advisory Committee on Dangerous Pathogens. Spongiform Encephalopathy Advisory Committee. Transmissible spongiform encephalopathy agents: Safe working and the prevention of infection. London: The Stationery Office; 1998:1-54.
47. World Health Organization. WHO infection control guidelines for transmissible spongiform encephalopathies: Report of a WHO consultation, Geneva, Switzerland, 23-26 March 1999. Available at: "www.who.int/csr/resources/ publications/bse/WHO_CDS_CSR_APH 2000_3/en/". Accessed Sept. 29, 2003.
48. Department of Health. CJD incidents panel: management of possible exposure to CJD through medical procedures - a consultation paper. Available at: "www.doh.gov.uk/cjd/consultation". Accessed Sept. 16, 2003.
49. Flechsig E, Hegyi I, Enari M, Schwarz P, Collinge J, Weissmann C. Transmission of scrapie by steel-surface-bound prions. Mol Med 2001;7:679-84.
50. Porter SR, Scully C, Ridgway GL, Bell J. The human transmissible spongiform encephalopathies (TSEs): implications for dental practitioners. Br Dent J 2000;188:432-6.
51. Porter SR. Prions and dentistry. J R Soc Med 2002;95:178-81.
52. Department of Health. Risk assessment for vCJD and dentistry. Available at: "www.doh.gov.uk/cjd/dentistryrisk/index.htm". Accessed Sept. 18, 2003.